Ligand validation:2QVU

FDP: 2,6-di-O-phosphono-beta-D-fructofuranose

FDP is a Ligand Of Interest in 2QVU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2QVU_FDP_A_338	93%	64%	0.077	0.973	0.76	0.61	1	-	0	0	100%	1
2QVU_FDP_B_339	92%	62%	0.087	0.976	0.81	0.64	1	-	0	0	100%	1
2QVV_FDP_A_402	91%	65%	0.081	0.968	0.75	0.6	1	-	0	0	100%	1
1FRP_FDP_A_336	84%	31%	0.108	0.971	0.93	1.77	1	10	0	0	100%	1
4GWU_FDP_A_401	64%	49%	0.164	0.964	0.85	1.13	1	2	5	0	100%	1
3HQP_FDP_J_700	99%	38%	0.053	0.991	1.08	1.36	2	4	0	0	100%	1
4KCT_FDP_B_1004	99%	51%	0.064	0.993	0.95	0.93	1	1	0	0	100%	1
4KCV_FDP_A_1004	96%	51%	0.083	0.993	0.99	0.91	1	-	0	0	100%	1
4HYV_FDP_B_1004	95%	37%	0.084	0.99	1.3	1.17	2	2	0	0	100%	1
5Q0C_FDP_C_402	95%	38%	0.079	0.983	1.04	1.4	-	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.